Fast Track designation News
Most Popular Fast Track designation Story
ALSO NOTED: Novartis sinks$816.5M into Italian vaccine plant; GSK, Astellas take a pass on Theravance's drugs; and much more...
> Novartis is pledging to sink €600 million ($816.5 million) into new and expanded facilities in Italy. Read more...
Latest Headlines
- December 3, 2007
- December 3, 2007
- July 20, 2006
- January 19, 2006
- January 11, 2006
- November 10, 2005
- November 6, 2005
- November 6, 2005
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
